Leerink raised the firm’s price target on Spruce Biosciences (SPRB) to $160 from $10 and keeps a Market Perform rating on the shares. Spruce is ...
TransAlta (TSX:TA) shares have bounced back over the past month, gaining 24%. Investors have taken notice as the stock shakes off earlier volatility and offers a fresh perspective on the company’s ...
Target CEO Brian Cornell on Wednesday warned of "massive potential costs" due to tariffs, saying the company would raise prices as a "very last resort." "The difficulty level has been incredibly high ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback